Related Experiment Video
Updated: Jan 11, 2026
09:29
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.3K
ADAM10 Knockout from Human Glioblastoma and Colon Cancer Cells Modulates Diverse Signalling Networks and Inhibits
Hengkang Yan1,2, Sakshi Arora1,2, Linda Hii3
1Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
International Journal of Molecular Sciences
|November 13, 2025
Summary
ADAM10 (a metalloprotease) is crucial for glioblastoma and colon cancer growth by influencing the tumor microenvironment. Gene knockout severely delayed tumor growth, highlighting ADAM10
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- ADAM10 is a metalloprotease involved in shedding membrane proteins, impacting cell signaling.
- High ADAM10 expression correlates with poor prognosis in glioblastoma multiforme (GBM) and gastrointestinal (GI) cancers.
- ADAM10's role in tumor development and the tumor microenvironment (TME) requires further investigation.
Purpose of the Study:
- To investigate the function of ADAM10 in GBM and colon cancer models.
- To assess the impact of ADAM10 gene knockout (KO) on tumor growth, protein shedding, and expression.
- To explore the clinical relevance of ADAM10 and its associated protein sets in human cancers.
Main Methods:
- Gene knockout (KO) of ADAM10 in U251 GBM and SW620 colon cancer cells.
- Assessment of cell proliferation, tumor xenograft growth in mice, and protein shedding.
- Proteomics analysis of conditioned medium and cell/tumor lysates.
- Analysis of human GBM and colon cancer patient data (TCGA).
Main Results:
- ADAM10 KO severely delayed tumor xenograft growth, with modest effects on in vitro proliferation, suggesting a key role in the TME.
- Proteomics revealed decreased levels of known ADAM10 targets (e.g., Notch, Eph receptors) and proteins involved in cell adhesion, migration, signaling, metabolism, angiogenesis, and cell-matrix organization.
- ADAM10 KO tumors showed reduced collagen and blood vessels, but increased chondrocyte differentiation, indicating ADAM10's role in maintaining an undifferentiated phenotype.
- Results in GBM and colon cancer models were consistent, and protein set correlations with ADAM10 expression were observed in human cancer specimens.
Conclusions:
- ADAM10 plays a significant role in tumor development and the TME across different cancer types.
- ADAM10 influences diverse signaling pathways, including those regulating cell-matrix interactions, angiogenesis, and differentiation.
- Targeting ADAM10 may offer a therapeutic strategy for GBM and other cancers.
Related Concept Videos
02:43Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K